Eurofins PSS Insourcing Solutions’ Post

We support to enhance sales performance and facilitate global expansion. Leveraging our deep understanding of the life sciences and pharma sectors, Ivy Consulting empowers businesses to thrive in a competitive market, ensuring sustainable growth and success. Advantages for your Firm: ✓ MORE EFFECTIVENESS: Ivy Consulting employs a holistic marketing approach, offering advice on both strategic planning and day-to-day business activities. ✓ MORE EFFICIENCY: you can penetrate and develop international markets, achieving your business goals in less time and with the right investment. ✓ FOCUS ON YOUR CORE ACTIVITIES: By entrusting Ivy Consulting with your international commercial business, you can concentrate better on your company's core activities. ✓ COST SAVING: The support of Senior Consultants translates into time savings and increased efficiency. ✓ SAVING TRAINING COSTS: Thanks to IVY Senior Consultants, you can reduce costs associated with training and managing human resources. For more information, feel free to reach out and ask for further details: Giovanni Carducci or leave a message: https://lnkd.in/dh_P_pXx #DiagnosticsIndustry #Pharmaceuticals #LifeSciencesSolutions #BiotechConsulting #GlobalBusiness #InternationalTrade #MarketEntry #GlobalPartnerships

In the intricate tapestry of Pharmaceutical Manufacturing, there's a transformative tool that's gaining momentum yet often remains overshadowed by more quantifiable metrics: Empathy Mapping. At The i+D.e. Agency, our core belief resonates with the transformative power of understanding and listening. It's not just about the machinery's hum or the data charts—it's about every whispered challenge, every unvoiced aspiration, and the collective rhythm of the teams driving groundbreaking innovations. When each department, from the visionary minds in R&D to the diligent hands in Production, embraces a unified language rooted in empathy, the outcomes are nothing short of groundbreaking. Enhanced efficiency, a bridge of trust across teams, and a workforce passionately aligned with its mission. Venture into the future landscape of Pharma with our unparalleled Systems & Design Thinking strategies. Together, let's elevate empathy from being a mere sentiment to the bedrock of transformative progress. #future  #pharmaceuticalindustry  #pharmaceuticalmanufacturing  #innovation #pharmaceuticals

💥 Global Pharmaceutical Companies' Employee Compensation Showdown #EndpointsNews conducted a survey of the median #employeecompensation for 177 #lifescience companies in 2023. The video content pertains to the compensation situation at the largest companies in this field—based on the latest annual reports of the companies, all of which are global #pharmaceutical manufacturers with at least 10,000 employees (in the industry as a whole, many of the companies with the highest compensation are smaller biotech firms, whose employees are primarily concentrated in the high-cost R&D and leadership functions). It should be noted that not all pharmaceutical manufacturers disclose information using the same methods. Although the U.S. Securities and Exchange Commission （#SEC） requires these companies to publish the median employee compensation, the agency allows companies to use different methods to calculate the total. For example, #Pfizer focuses only on the cash compensation of employees, while other companies such as #EliLilly and #Regeneron include the estimated value of any equity awards granted last year. The survey also uses similar metrics, which are not uniform, including some giants listed abroad, such as #AstraZeneca and #NovoNordisk. For instance, AstraZeneca disclosed the typical compensation of its median employee in the UK. 👍 #BeiGene from #China made the list. Cheers!~ For more news about #pharma, #biotech, #drugdiscovery, #drugdevelopment, etc., please visit https://lnkd.in/ghaauBTC Many thanks!~

W. Edwards Deming's poignant statement, “All models are wrong; some models are useful,” offers a critical lesson in humility and practicality for any industry reliant on data and analytics. It's a reminder that while models are indispensable tools for understanding and navigating complex systems, they are ultimately simplifications of the real world. This awareness is particularly crucial in the ever-evolving landscape of Pharmaceutical Manufacturing, where relying too rigidly on any single model can lead to oversights in an environment characterized by nuance and variability. The i+D.e. Agency takes this wisdom to heart, applying Systems & Design Thinking to not only utilize models for their utility but also to constantly challenge and refine them. This ensures that our strategies and solutions remain adaptable, innovative, and most importantly, aligned with the multifaceted nature of real-world challenges. hashtag #future #pharmaceuticalindustry #pharmaceuticalmanufacturing #innovation #pharmaceuticals

The pharmaceutical industry is not exempt from the sweeping impact of the digital revolution, which is compelling companies to rethink their operational strategies. In this rapidly evolving landscape, frontline workers are particularly vulnerable, facing concerns about job security. This uncertainty can diminish their engagement and hinder their productivity. Therefore, leaders in pharmaceutical companies must recognize this challenge and take deliberate action to address it. Two essential steps to consider are: 1. Implementing training programs to equip frontline workers with the necessary skills to adapt to changing technologies. 2. Encourage fostering a culture of continuous improvement within the organization. Learn more about how you can take these steps from the solutions page here - https://lnkd.in/d9UcjtEN #FrontlineWorkers #trainingPrograms #DaleCarnegie #DaleCarnegieIndia

Assessing the competitive landscape is vital when contemplating the launch of a new business or product into a new market. Identifying key competitors and understanding their strengths, weaknesses, and market positioning will drive the development of a competitive strategy.     Financial considerations are critical. Understanding the initial and ongoing investment required, forecasting the potential revenue streams, and expected return on investment help gauge the financial feasibility of a business's expansion. Evaluating the business's internal capabilities and resources is equally important. Understanding whether a company possesses the necessary expertise, human capital, technology, and financial resources to support market entry and sustain operations is crucial.    Only through meticulous analysis and strategic planning can businesses minimise risks and seize opportunities for successful expansion.    Axis Health Co is a Strategic Consultancy that offers access to the greatest diversity of local experts who will provide practical and independent advice. Contact us for a confidential discussion contactus@axishealthco.com #healthcare #pharmaceutical #medicaldevices #medtech #biotech #strategicconsulting #businessconsulting #commercialisation

In the fast-evolving landscape of drug development, sustainability is no longer just an option—it's a necessity. Lyn McNeill from Almac highlights the power of 𝐣𝐮𝐬𝐭-𝐢𝐧-𝐭𝐢𝐦𝐞 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 (𝐉𝐈𝐓) in creating sustainable supply chains. By eliminating waste and optimizing inventory, JIT not only enhances efficiency but also significantly reduces environmental impact. It’s time for sponsors to rethink their strategies and embrace innovative solutions that align with modern sustainability goals. Let’s lead the charge towards a greener 𝐟𝐮𝐭𝐮𝐫𝐞 𝐢𝐧 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬! 🔗 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐡𝐨𝐰 𝐉𝐈𝐓 𝐜𝐚𝐧 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦 𝐲𝐨𝐮𝐫 𝐬𝐮𝐩𝐩𝐥𝐲 𝐜𝐡𝐚𝐢𝐧: https://lnkd.in/gxU8-65r 𝐕𝐢𝐬𝐢𝐭 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚: https://lnkd.in/gxQcREqb #JustInTime #SustainableManufacturing #Pharmaceuticals #SupplyChain #Innovation #WasteReduction #GreenPharma #Almac #LynMcNeill #Efficiency #DrugDevelopment #Sustainability #EcoFriendly #FutureForward #ResponsibleManufacturing

Ever felt the Amazon Effect? The demand for lightning-fast delivery is reshaping industries, even in Life Sciences. Our survey last year revealed fascinating insights: 70% of surveyed companies are relocating operations closer to customers, and 33% prioritize delivery timelines in supply chain decisions. For medical device and pharmaceutical companies, this means a seismic shift. Your clients now expect Amazon-level speed. Is your distribution strategy up to par? It's time to rethink and adapt. Consider outsourcing to nimble third parties for swift execution. Interestingly, our survey found that 79% already outsource over a quarter of production, and 75% actively seek to offload more. The trend is clear – companies are exploring partnerships to meet rising speed expectations. Are you among the forward-thinkers looking to enhance your processes this year? What delivery demands are you facing from clients, end-users, and partners? Let's discuss the evolving landscape of Life Sciences and how we can optimize your strategy. #MedicalDevice #Pharmaceutical #SupplyChainOptimization #packagingsolutions

🚀 Challenges in Pharmaceutical Manufacturing 2024 🚀 It's not been an easy year for pharmaceutical manufacturing, requiring companies to be agile and strategic in their approach to remain competitive. Speaking with my clients, some key hurdles have been: Regulatory Compliance: Stricter regulations and pricing pressures, especially with the Inflation Reduction Act in the US. Supply Chain Disruptions: Ongoing complexities and the need for resilience in global supply chains. Rising Operational Costs: Inflation impacting labor, materials, and transportation. Talent Shortages: Difficulty in finding skilled candidates within budget. Technological Adaptation: Integrating AI and managing cybersecurity risks. How is your organization adapting to these changes? 💡 #Pharmaceuticals #Manufacturing #Healthcare #Innovation #SupplyChain

What is #opportunity #cost with an example? Opportunity costs are the costs incurred due to the need to divert #expenditures to #regulatory #compliance and away from preferred (i.e. more #productive) uses. An opportunity cost is the #value of the option not taken when a #business makes a #decision. For example, if the business is deciding whether to register two new #pharmaceutical products, the opportunity cost of not doing so would be the potential #revenue and #profitability lost by not being able to take on another project. #workshops pdf link: https://lnkd.in/dr-csNfd For more details join #telegram group link: https://lnkd.in/d-Xv7v_p #healthcare #economics #ra